ASTRAZENECA'S CUSTOMER OPERATIONS
BUSINESS HOURS AND HOLIDAY SCHEDULE

AstraZeneca's Trade Customer Operations Business Hours
Monday through Thursday 8 AM - 5PM
Fridays 8 AM - 3PM

2008 Holiday Schedule

• $15,000.00 minimum order
  
• Emergency orders - Please contact the Customer Service Department at 1-800-842-9920
• Orders must be placed in correct multiples
• Controlled Substance Orders - Mail purchase order along with 222 form to AstraZeneca, 50 Otis Street, Westborough, MA 01581

EXPIRED RETURN GOODS POLICY
UPDATED as of April 2007

• Eligible expired products are the following product categories manufactured and/or distributed only by AstraZeneca LP or AstraZeneca Pharmaceuticals LP in the United States and identified by the NDC labeler codes indicated below:
  a) Product Categories:
          - Non-controlled Pharmaceutical Retail Distribution Products
          - Controlled Substance Pharmaceutical products
  b) NDC Labeler Code(s):
          - 00310
          - 00186
  
• Expired product must be within six (6) months of expiration but cannot be out of date by more than one (1) year. Retail Distribution Products that do not meet the aforementioned timeframe will not be credited.

• All expired product must be sent directly to Stericycle Pharmaceutical Services, Conyers, GA (1-800-777-6565) and/or Stericycle Pharmaceutical Services, Indianapolis, IN (1-877-546-8441). Expired product that is sent to Stericycle Pharmaceutical Services, must be between Monday through Friday (except holidays). Both locations will hereinafter be referred to as “Return Goods Processor”.
• Authorization from Return Good Processor is required to return eligible EXPIRED PRODUCT. Please contact Return Goods Processor to obtain Return Authorization Form (RAF).
• Please ensure that the RAF has the name, address, & DEA number of the indirect and or the direct customer to be credited, and include a copy of the debit memo with the return.

• Eligible products shipped to Return Goods Processor are to be addressed and shipped to either:
  

  Stericycle Pharmaceutical Services		Stericycle Pharmaceutical Services
  2084-900 Lake Industrial Court		2670 Executive Drive
  Dock I9		Indianapolis, IN 46241
  Conyers, GA 30013
  (800) 777-6565		(877) 546-8441

• All eligible products shipped to Return Goods Processor are to be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes.
• Shipping charges for all shipments to Return Goods Processor are to be prepaid by Buyer. Seller is not obligated to pay for charges incurred by Buyer for return goods processing.
• Shipments sent COD (collect on delivery) will be refused by Return Goods Processor.
• It is the shipper's responsibility to securely package all returned products to prevent breakage during transit and otherwise comply with laws and regulations applicable to the packaging, shipping and transport of returned goods.
• Broken product containers/bottles, without product present, are NOT to be shipped to Return Goods Processor. If any are shipped to Return Goods Processor, they will be disposed of and will not be reported as a return.
• In the case where the Return Goods Processor may receive broken product containers/bottles that occurred during shipment, the Return Goods Processor will accept damaged, broken, wet and/or leaking shipping containers. Such returns will be processed, but no credit will be issued. Seller’s credit memo to Buyer will indicate no credit due to damaged container.

• Reimbursements will be issued as provided below based on the current retail acquisition cost (WAC) less five percent (5%) of the merchandise returned, unless otherwise required by applicable law. Direct Contracted Buyers’ reimbursement will be issued based on current contract price less five percent (5%) of the merchandise returned, unless otherwise required by applicable law.
• Reimbursements will be determined on the basis of actual count. Credit will be issued for the actual amount of tablets/capsules returned in a given container. For example, if 15 tablets/capsules are returned in a 30-count bottle, credit will be issued for 15 tablets/capsules only. For liquid, syringe, injectable, cream and ointment products, credit will be issued for sealed units of an inner pack. No credit will be issued for all others.
• Reimbursements will be net of any assessments on AstraZeneca for credit memo processing/handling.
• Credit will be issued to retailers and/or other direct accounts. For indirect customers, credit will be issued through their retailer or direct account.
• Returned goods may not be exchanged for replacement merchandise.

• Buyer must contact Return Goods Processor at phone number designated above to obtain a Schedule II Return Request Form.
• Buyer must complete the Schedule II Return Request Form as instructed, including the NDC number and quantity of the items being returned, and return to the indicated address.
• Return Goods Processor will send Buyer a DEA Form 222 with packing and shipping instructions and a tamper-resistant bag.
• Schedule II products must be returned separate and apart from Schedule III, IV, and V products and non-controlled products. Items must be packaged by Buyer in the tamper-resistant bag and the bag placed inside a separate shipping carton with proper packing material.
• Schedule II returns must be shipped in an unmarked container via common carrier. Small quantities may be shipped via US registered mail, return receipt requested.

• Not in Original Container:
  All products must be in their original container. Seller will not issue credit for products returned in original containers with prescription labels attached. Seller will not issue credit for products returned in prescription containers. Seller will not issue credit for any repackaged product.
• Over packed Container:
  Credit will be issued for only the specified amount of the original container quantity. For example, if 45 tablets are returned in a 30-count bottle, credit will be issued for 30 tablets only. The other 15 tablets will be destroyed, with no credit issued.
• Empty Container:
  Credit will not be issued for returns of AstraZeneca containers that contain no viable product. For example, credit will not be issued for a return for remnants of crushed tablets that exist in a container.
• Partial Reimbursement Policy:
  Tablets and Capsules - Credit will be issued based on actual count.
  Liquid, Syringe, Injectable, Cream and Ointment Retail Distribution Products – Credit will be issued for sealed units of an inner pack. No credit will be issued for all others.
• Missing Lot or Expiration Date:
  No credit will be issued if the lot number or expiration date is missing, illegible, covered, and/or unreadable on original container.
• No containers labeled “sample” will be credited.
• Returned quantities will be audited by Return Goods Processor, and final credit will be based on Return Goods Processor’s count.
• Retail Distribution Products unacceptable for credit will not be returned to the Buyer but will be destroyed. Buyer will receive notification for non-credited items.
• Seller will not issue credit for non-Seller products.
• Retail Distribution Products damaged by fire, smoke, heat, or water resulting from fire or other insurable hazards is not returnable under this Policy.
• Distress merchandise, such as items purchased from bankruptcy sales, going-out-of-business sales, fire sales, or other merchandise generally considered under the classification “distress merchandise”, is not returnable under this Policy.

• Discontinued product NDCs will be evaluated by Seller on a case-by-case basis for potential return prior to becoming expired.

• Seller is not responsible for shipments lost and/or damaged in transit. It is recommended that all Buyers insure return goods shipments.
• Seller’s Pharmaceutical Sales Specialists and/or Office-Based Representatives are not authorized to approve the return of merchandise or to accept merchandise for return.
• Seller can modify this policy at any time upon written notice.

For purposes of this policy, references to Seller mean (a) AstraZeneca Pharmaceuticals LP (“AZPLP”) as regards all goods or services identified by an AZPLP product code, labeler code or NDC number on the invoice or (b) AstraZeneca LP (“AZLP”) as regards all goods or services identified by an AZLP product code, labeler code or NDC number on the invoice. AZLP is a sales agent for AZPLP and has authority to act for AZPLP in connection with the sale of AZPLP goods or services. In the absence of a product code, labeler code or NDC number for a particular good or service, Seller shall mean either AZPLP or AZLP as expressly identified on the invoice as regards to such good or service.